You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Durable Stretch Barrier Materials

    SBC: LaunchBay LLC            Topic: CBD181003

    Chemical, Biological, Radioactive and Nuclear (CBRN) protective ensembles are widely used by the US Military and civilian first responders as the first line of defense for personnel working in contaminated environments. Many innovative products have been developed for the chemical protective clothing market in response to demand from the market place for improved performance. However, the need for ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. Dual Formulation of Atropine and Scopolamine with Enhanced Stability

    SBC: Nano Terra, Inc.            Topic: CBD181005

    The standard US military treatment for nerve agent exposure is application of up to three autoinjectors, each containing atropine sulfate and 2-pralidoxime, to counteract symptoms of nerve agent intoxication and restore acetylcholinesterase activity. This treatment increases survival rates after nerve agent exposure, however, seizures resulting from nerve agent poisoning are a common symptom that ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  3. Dual Formulation of Atropine/Scopolamine with Enhanced Stability

    SBC: CMC PHARMACEUTICALS INC            Topic: CBD181005

    CMC Pharmaceuticals, Inc. (Cleveland, OH) is proposing developing a stable, combination product of two small molecule drug candidates as a counter measure to chemical warfare nerve agents (NA). The combination product is expected to exploit complementary pharmacological profiles for optimal muscarinic receptor blockade and anticholinergic activity within the peripheral and central nervous system. ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  4. Field Portable Mass Spectrometry for Small Molecule Drugs in Clinical Samples

    SBC: SPECTRAL ENERGIES LLC            Topic: CBD181006

    We propose a novel two-dimensional mass spectrometry (2D-MS) technique based on ion trap arrays to identify illicit and designer drugs. This approach will give an unprecedented multiplex advantage for miniature mass spectrometry, allowing novice field technicians to rapidly identify drugs affecting the central nervous system based on both the m/z ratio and fragmentation pattern of an ion. Towards ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  5. Clinical Decision Support for Dermatology Diagnosis in No-Communications Theater Environments

    SBC: 3Derm Systems, Inc.            Topic: DHA182001

    This proposal will investigate the requirements for an automated system that can provide triage, treatment, and diagnostic support for skin infections and other non-domestic dermatological conditions military personnel are at risk of contracting. 3Derm Sy

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  6. Extended Wear Deep-Fitting Noise Dosimeter

    SBC: TRITON SYSTEMS, INC.            Topic: DHA182002

    Triton Systems proposes to develop a deep fitting in-the-ear, extended-wear acoustically transparent dosimeter to accurately measure levels and amount of noise exposure near the ear drum.

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  7. A portable, light-weight, gaspowered, cooling device (PLCD, Portable Limb Cooling Device) for prolonged field damage control of injured ischemic limbs

    SBC: Moveo Walks, Inc.            Topic: DHA182003

    We hypothesize that a combination of advanced insulating fabrics and a cooling method (gas-operated) can be integrated into a portable, light-weight device for field/en route controlled limb cooling. We aim to fabricate a prototype portable device for li

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  8. Identification of Open Globe Injuries on the Battlefield

    SBC: TRITON SYSTEMS, INC.            Topic: DHA182004

    Triton Systems, Inc., and our team propose to develop a handheld diagnostic to detect ocular wounds to improve outcomes for both military warfighters and the civilian market. Our device will possess the following benefits: 1) biocompatibility, 2) it will

    SBIR Phase I 2019 Department of DefenseDefense Health Agency
  9. CRANE: Cervical Readiness Using Analytics and Non-Invasive Evaluation

    SBC: APTIMA INC            Topic: DHA18B001

    Current cervical spine assessment methodologies are focused on subjective measures (i.e. pain reports) and range-of-motion (ROM) measures that only measure maximum head excursion and reach, but not dynamic motion. Due to report bias and existing incentive

    STTR Phase I 2019 Department of DefenseDefense Health Agency
  10. Cervical Spine Health Improvement Products

    SBC: SWITCHBOX INC            Topic: DHA18B001

    Most standard-of-care tools and techniques for evaluating neck disorders are subjective, unreliable, and do not provide actionable information for providers, payers, and organizations to deliver efficient and effective care. This lack of objective neck he

    STTR Phase I 2019 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government